Equities

Cisen Pharmaceutical Co Ltd

603367:SHH

Cisen Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)14.83
  • Today's Change0.00 / 0.00%
  • Shares traded3.30m
  • 1 Year change+0.27%
  • Beta0.5913
Data delayed at least 15 minutes, as of Jun 17 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.

  • Revenue in CNY (TTM)4.48bn
  • Net income in CNY528.35m
  • Incorporated1998
  • Employees3.40k
  • Location
    Cisen Pharmaceutical Co LtdNo.16 Tongji Road, Hi-tech ZoneJINING 272073ChinaCHN
  • Phone+86 5 372989906
  • Fax+86 5 372215851
  • Websitehttp://www.cisen-pharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Ausun Pharmaceutical Co Ltd855.13m272.71m6.41bn1.17k23.482.83--7.500.46040.46041.443.820.28761.213.71728,389.909.179.3812.2912.8454.1453.0931.8927.141.96--0.159223.536.8327.357.8742.0724.3250.50
Chengdu Easton Biopharmaceuticals Co Ltd1.15bn240.60m6.48bn1.40k26.852.45--5.622.012.019.6522.070.35661.547.73824,469.807.438.729.1510.6477.9285.1020.8419.162.59--0.086126.80-4.567.76-8.0910.9117.99--
Shouyao Holdings Co Ltd5.23m-191.79m6.62bn185.00--6.84--1,266.17-1.29-1.290.03526.510.00450.26445.2528,265.68-16.55-37.24-18.01-42.6396.5096.03-3,667.74-2,251.778.49--0.0018--186.18-23.51-6.76--34.59--
Cisen Pharmaceutical Co Ltd4.48bn528.35m6.71bn3.40k12.741.14--1.501.161.169.8613.020.60822.815.651,315,959.007.216.949.028.5657.3356.2711.8510.773.12--0.037333.429.753.2248.920.697-15.1910.72
Beijing Foyou Pharma Co Ltd3.32bn507.64m6.80bn3.44k13.351.93--2.051.061.066.957.350.74823.469.58967,165.9011.50--14.81--65.14--15.37--2.99--0.0316--3.07--11.36------
Shandong Lukang Pharmaceutical Co Ltd6.28bn267.79m6.83bn6.48k26.091.86--1.090.2920.2926.884.110.71873.546.45967,865.703.212.215.514.0523.5523.414.473.460.73135.390.468931.799.3413.0478.378.81-16.9523.94
JiangSu WuZhong Pharmactcl Devlpm Co Ltd2.33bn-95.04m6.99bn1.05k--3.95--3.00-0.1335-0.13353.222.480.55316.072.292,220,525.00-2.31-2.92-4.78-5.3022.4128.14-4.18-5.771.22-0.32320.5063--10.555.655.58---19.08--
Harbin Pharmaceutical Group Co., Ltd.15.67bn449.71m7.03bn9.85k15.271.43--0.4490.18270.18276.341.951.136.353.461,590,093.003.790.741410.201.8926.3023.873.350.72941.0640.410.3930.0011.937.41-14.882.69-5.38--
Data as of Jun 17 2024. Currency figures normalised to Cisen Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.40%Per cent of shares held by top holders
HolderShares% Held
ABC-CA Fund Management Co., Ltd.as of 31 Dec 20231.60m0.36%
Great Wall Fund Management Co., Ltd.as of 31 Dec 2023900.00k0.20%
Dimensional Fund Advisors LPas of 06 Jun 2024690.80k0.15%
Bank of China Investment Management Co., Ltd.as of 31 Dec 2023637.50k0.14%
Penghua Fund Management Co., Ltd.as of 31 Dec 2023551.50k0.12%
Essence Fund Co., Ltd.as of 31 Dec 2023517.80k0.12%
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023455.80k0.10%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023369.80k0.08%
UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023311.90k0.07%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023292.60k0.07%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.